
Boston Scientific Corporation BSX
$ 97.69
-0.71%
Quarterly report 2025-Q3
added 11-03-2025
Boston Scientific Corporation DSO Ratio 2011-2026 | BSX
Annual DSO Ratio Boston Scientific Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 65.7 | 59.7 | 62.4 | 64.1 | 62.2 | 58.5 | 66.8 | 61.3 | 59.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 66.8 | 58.5 | 62.3 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
39.2 | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Alphatec Holdings
ATEC
|
46.4 | $ 22.27 | -1.81 % | $ 3.18 B | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
AxoGen
AXGN
|
48 | $ 34.32 | 2.83 % | $ 1.52 B | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Apyx Medical Corporation
APYX
|
85.8 | $ 3.57 | 3.03 % | $ 124 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
66.9 | $ 320.06 | 0.35 % | $ 9.03 B | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 9.53 | -0.31 % | $ 684 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
67 | $ 42.47 | -3.99 % | $ 1.31 B | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 52.88 | 0.76 % | $ 7.88 K | ||
|
Abbott Laboratories
ABT
|
58.7 | $ 125.59 | -0.46 % | $ 219 B | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.7 | -2.37 % | $ 138 M | ||
|
Electromed
ELMD
|
137 | $ 29.04 | -0.46 % | $ 246 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
InMode Ltd.
INMD
|
5.36 | $ 14.21 | -0.35 % | $ 1.13 B | ||
|
IRIDEX Corporation
IRIX
|
45.6 | $ 1.2 | 0.42 % | $ 19.4 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Align Technology
ALGN
|
86.7 | $ 171.39 | 0.47 % | $ 12.8 B | ||
|
Accuray Incorporated
ARAY
|
69.7 | $ 0.87 | -1.91 % | $ 89.4 M | ||
|
IRadimed Corporation
IRMD
|
56.8 | $ 99.75 | -0.25 % | $ 1.26 B | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
46.1 | $ 15.36 | 0.33 % | $ 415 M | ||
|
FONAR Corporation
FONR
|
237 | $ 18.58 | 0.11 % | $ 122 M | ||
|
LENSAR
LNSR
|
34.4 | $ 11.73 | 0.47 % | $ 135 M | ||
|
Globus Medical
GMED
|
76.9 | $ 92.18 | -2.56 % | $ 12.5 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 13.61 | -1.84 % | $ 1.05 B | ||
|
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | ||
|
Myomo
MYO
|
0.704 | $ 0.99 | 0.92 % | $ 6.98 M | ||
|
Establishment Labs Holdings
ESTA
|
123 | $ 69.38 | -4.85 % | $ 1.95 B | ||
|
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M |